A randomized clinical trial of triamcinolone acetonide injection for suppression of inflammation after blepharoptosis surgery.

Masashi Mimura, Takayuki Matsuura, Mai Takagi, Koichiro Taki, Yohei Sato, Yasushi Fujita, Hidehiro Oku, Tsunehiko Ikeda

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2022 May

filter terms:

This study aimed to determine the effectiveness of triamcinolone acetonide in suppressing inflammation after blepharoptosis surgery. The study was designed as prospective, randomized, two medical centers' clinical trial. Thirty-two patients with involutional blepharoptosis of the same degree in both eyelids underwent bilateral transcutaneous levator advancement. At the end of the surgery, 4 mg/0.1 ml of triamcinolone acetonide was injected into a randomly selected upper eyelid. The fellow eyelid was not injected and was used as control. Facial photographs were taken on day 1, week 1, month 1, and month 3, and the degree of inflammation, the margin reflex distance 1 (MRD-1), and levator function (LF) between the two eyelids of each patient were compared. The primary outcome was the selection of the less inflamed eyelid decided by the majority of three individuals unrelated to the study. MRD-1 and LF were analyzed for secondary outcomes. As a result, the injected eyelid was judged to be the less inflamed eyelid in all cases. The MRD-1 in the postoperative period less than 1 month was significantly larger in the injected eyelids than the control eyelids (P<0.03). The postsurgical MRD-1 at month 3, the postsurgical LF at all postsurgical examination times were not statistically different. Adverse complications by the injection, including ptosis, levator dysfunction, increase of the intraocular pressure, and visual disturbance were not observed. In conclusion, a triamcinolone acetonide injection after ptosis surgery is both safe and effective in reducing the early postsurgical inflammation and helpful in an earlier return to a daily routine for the patients. Copyright © 2021 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Citation

Masashi Mimura, Takayuki Matsuura, Mai Takagi, Koichiro Taki, Yohei Sato, Yasushi Fujita, Hidehiro Oku, Tsunehiko Ikeda. A randomized clinical trial of triamcinolone acetonide injection for suppression of inflammation after blepharoptosis surgery. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2022 May;75(5):1744-1749